Medigus Ltd. — Form D/A
Medigus Ltd. of OMER, L3, a company, filed a Form D amendment with the SEC on 2014-09-05. The offering totals $5.6M, of which $5.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-09-05
- Form: D/A
- Accession: 0001618500-14-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.6M
- Amount sold: $5.6M
- Investors: 5
- Date of first sale: 2014-08-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-224129
Issuer
- Name: Medigus Ltd.
- CIK: 0001618500
- Entity type: Other
- Jurisdiction: ISRAEL
- Address: BUILDING 7A, OMER INDUSTRIAL PARK, OMER, L3, 8496500
- Phone: 972722602211
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Erez Chimovitz | Director | Omer, L3 |
| Ori Hershkowitz | Director | Omer, L3 |
| Yari Rabinowitz | Director | Omer, L3 |
| Chistopher Rowland | Director | Omer, L3 |
| Avraham Sarusi, Gabby | Director | Omer, L3 |
| Thomas Dempsey | Executive Officer | Omer, L3 |
| Chistopher Rowland | Executive Officer | Omer, L3 |
| Jeremy Starkweather | Executive Officer | Englewood, CO |
| Doron Birger | Director | Haifa, L3 |
| Avraham Ben-Tzvi | Executive Officer | Berkeley Heights, NJ |
| Nissim Darvish | Director | Tel Aviv, L3 |
| Ori Hershkovitz | Director | Rehovot, L3 |
| Eitan Machover | Director | Tel Aviv, L3 |
| Oded Yatzkan | Executive Officer | Omer, L3 |
| Efrat Venkert | Director | Omer, L3 |
| Christopher Rowland | Director | Omer, L3 |
| Christopher Rowland | Executive Officer | Omer, L3 |
| Aviel Roy-Shapira | Executive Officer | Omer, L3 |
| Minelu Sonnenschein | Executive Officer | Omer, L3 |
| Yaron Silberman | Executive Officer | Omer, L3 |
| Anat Naschitz | Director | Omer, L3 |
| Milena Ridl | Executive Officer | Omer, L3 |
Other filings by this issuer (3)
More